Jim Simons's position in Arrowhead Pharmaceuticals is currently worth $2.84 Million. That's 0.00% of their equity portfolio (1634th largest holding). The first Arrowhead Pharmaceuticals trade was made in Q2 2017. Since then Jim Simons bought shares eight more times and sold shares on eleven occasions. The investor's estimated purchase price is $5.32 Million, resulting in a loss of 47%.